Clinical trials
Prognosis clinical trials
Below are recruiting prognosis clinical trials, each written for real people, not researchers. We’re tracking 236 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07246577Recruiting
Improving diagnosis and monitoring in giant cell arteritis
This study uses ultrasound, a biopsy of the temple artery, and blood tests to improve how giant cell arteritis (GCA) is diagnosed, monitored, and predicted. It may help doctors find better ways to manage this condition.
GothenburgAges 18 years+ - NCT07561814Recruiting
Predicting Pancreatic Cancer Treatment Outcomes Using Medical Images and Data
This study builds a computer model to predict how well pancreatic cancer patients will respond to surgery and what their long-term outcomes might be. Researchers use CT scans, blood tests, and medical records from patients who had pancreatic cancer surgery to teach the model to recognize patterns that help predict outcomes.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07263204Recruiting
AI for diagnosing and predicting hypertrophic cardiomyopathy
This trial uses artificial intelligence to help diagnose and predict outcomes for people with hypertrophic cardiomyopathy (HCM), a condition where the heart muscle becomes thickened. It may help doctors better understand your condition and plan your care.
Hangzhou, ZhejiangAges 18 years+ - NCT07280585RecruitingPhase 3
Testing a diabetes drug to slow kidney disease progression
This study tests whether a common diabetes medication (SGLT2 inhibitor) can help people with autosomal dominant polycystic kidney disease (ADPKD) maintain kidney function longer. If you have fast-growing kidney cysts and are between 18 and 60 years old, this trial may be an option.
FeldkirchAges 18–60 - NCT07311356Recruiting
Understanding early-onset anorexia prognosis
This study looks at the long-term outcomes for children hospitalized for anorexia nervosa. It aims to help doctors and families better understand the disease and improve care.
ParisAges birth–30 years - NCT07322627Recruiting
Esophageal cancer genetics and treatment outlook study
This study looks at a specific gene (ALDH2) in people with esophageal cancer to see if it affects how well they respond to treatment. It may help doctors better predict outcomes and personalize care.
TaipeiAges 18–99 - NCT07338539Recruiting
Shorter radiation for poor-prognosis GBM
This trial tests a shorter course of radiation (hypofractionated RT) for people with a specific type of aggressive brain tumor (GBM) that is not suitable for surgery. It aims to see if this shorter treatment can be effective with fewer side effects.
Mumbai, MaharashtraAges 50 years+ - NCT07345169Recruiting
Immune and inflammation study in ICU patients
This study looks at how your immune system and inflammation affect your recovery in the intensive care unit. Researchers want to understand why some patients do better than others.
ParisAges 18 years+ - NCT07670130Recruiting
Venetoclax TDM in Newly Diagnosed AML: Response and Outlook
This study looks at how the drug venetoclax works in people newly diagnosed with acute myeloid leukemia (AML). It helps doctors understand the right dose for better results.
SuzhouAges 16 years+ - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT07375433Recruiting
Heart failure and COPD study for patients aged 50 to 70
This trial looks at how heart failure with preserved pumping function affects people who also have COPD. It aims to understand the course of the disease and long-term outlook.
Kazan'Ages 50–70 - NCT07378176Recruiting
Study on outlook for primary aldosteronism patients
This study follows people with primary aldosteronism over time to understand their health outcomes. It may help doctors learn how to better treat this condition.
Chengdu, SichuanAges 18–80 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT07396662Recruiting
Pancreas Function and Recovery After Surgery
This study looks at how well the pancreas works (both hormone and digestive functions) and what happens to patients after pancreas removal surgery. It may help doctors better predict recovery and long-term health.
Taipei, TaiwanAges 20–75 - NCT02792075Recruiting
Study heart artery narrowing seen on special imaging
This study follows people who already have a heart artery imaging test to understand what the imaging means for future heart outcomes. It may help doctors predict prognosis and guide treatment for coronary narrowing.
Seoul, Songpa-guAges 19 years+ - NCT07414056Recruiting
Can blood tests predict lung injury in burned children?
This study is testing whether simple blood tests can predict a dangerous lung condition called ARDS in children with severe burns. Researchers will check the child's white blood cell and platelet counts to look for early warning signs that could help doctors treat them faster.
CairoAges 1–12 - NCT07421908Recruiting
Study on intrauterine adhesion treatment and outcomes
This study looks at how different treatments for intrauterine adhesions (scar tissue inside the uterus) affect long-term health. It aims to find which management approach works best for patients.
Changsha, HunanAges 18–45 - NCT07436845Recruiting
Emotion and treatment for advanced liver cancer
This trial studies if emotional health affects how well targeted therapy and immunotherapy work for people with advanced liver cancer. You will receive chemotherapy directly into the liver along with targeted drugs and immunotherapy.
Guangzhou, GuangdongAges 18 years+ - NCT07437742Recruiting
Pregnancy after endometriosis treatment
This study follows women with endometriosis who are trying to have a baby after medical or surgical treatment. It aims to learn how different treatments affect your chances of getting pregnant.
Milan, MI, ItaliaAges 18–40 - NCT07444853Recruiting
Improving recovery after brain hemorrhage
This study looks at people who come to the emergency room with a bleeding stroke (called intracerebral hemorrhage). It aims to learn more about the condition by studying blood tests and brain scans, to find ways to improve outcomes.
AngersAges 18 years+ - NCT07464938Recruiting
Predicting brain recovery after cardiac arrest
This study is testing new tools and markers to better predict recovery after cardiac arrest when brain injury may occur. It involves adults who had a cardiac arrest outside the hospital and are being treated at Saint-Luc hospital.
BrusselsAges 18 years+ - NCT07480512Recruiting
A study on causes and outcomes of coronary artery disease
This study follows people with different types of coronary artery disease over time to understand what causes their condition to get better or worse, and how well they do. The goal is to improve future treatment and care.
Guangzhou, GuangdongAges 18 years+ - NCT07482579Recruiting
Stroke Recovery Prediction Using a Digital Twin
This study uses digital twin technology to predict how well people will recover after a stroke. It looks at your walking ability and other factors to create a personalized recovery plan.
Gyeonggi-do, Gyeonggi-doAges 20 years+ - NCT07498959Recruiting
Surgery vs. chemo for testicular cancer that has spread
This study compares two standard treatments—surgery to remove lymph nodes in the abdomen (RPLND) versus chemotherapy—for men with testicular cancer that has spread to a small area in the abdomen. The goal is to see which approach works better and has fewer side effects.
Gothenburg, GöteborgAges 18 years+
Hear when a new Prognosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for prognosis?
- Yes. Clin2 currently lists 236 recruiting prognosis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a prognosis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a prognosis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.